• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过给予缺乏核转录因子-κB活性的树突状细胞预防非肥胖糖尿病(NOD)小鼠患糖尿病。

Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity.

作者信息

Ma Linlin, Qian Shiguang, Liang Xiaoyan, Wang Lianfu, Woodward Jennifer E, Giannoukakis Nick, Robbins Paul D, Bertera Suzanne, Trucco Massimo, Fung John J, Lu Lina

机构信息

Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

Diabetes. 2003 Aug;52(8):1976-85. doi: 10.2337/diabetes.52.8.1976.

DOI:10.2337/diabetes.52.8.1976
PMID:12882913
Abstract

Abnormalities of dendritic cells (DCs) have been identified in type 1 diabetic patients and in nonobese diabetic (NOD) mice that are associated with augmented nuclear transcription factor (NF)-kappaB activity. An imbalance that favors development of the immunogenic DCs may predispose to the disease, and restoration of the balance by administration of DCs deficient in NF-kappaB activity may prevent diabetes. DCs propagated from NOD mouse bone marrow and treated with NF-kappaB-specific oligodeoxyribonucleotide (ODN) in vitro (NF-kappaB ODN DC) were assessed for efficacy in prevention of diabetes development in vivo. Gel shift assay with DC nuclear extracts confirmed specific inhibition of NF-kappaB DNA binding by NF-kappaB ODN. The costimulatory molecule expression, interleukin (IL)-12 production, and immunostimulatory capacity in presenting allo- and islet-associated antigens by NF-kappaB ODN DC were significantly suppressed. NF-kappaB ODN renders DCs resistant to lipopolysaccharide stimulation. Administration of 2 x 10(6) NF-kappaB ODN DCs into NOD mice aged 6-7 weeks effectively prevented the onset of diabetes. T-cells from pancreatic lymph nodes of NF-kappaB ODN DC-treated animals exhibited hyporesponsiveness to islet antigens with low production of interferon-gamma and IL-2. These findings provide novel insights into the mechanisms of autoimmune diabetes and may lead to development of novel preventive strategies.

摘要

在1型糖尿病患者和非肥胖糖尿病(NOD)小鼠中已发现树突状细胞(DC)异常,这与核转录因子(NF)-κB活性增强有关。有利于免疫原性DC发育的失衡可能使个体易患该疾病,通过给予NF-κB活性缺陷的DC来恢复平衡可能预防糖尿病。评估了从NOD小鼠骨髓中培养并在体外用NF-κB特异性寡脱氧核糖核苷酸(ODN)处理的DC(NF-κB ODN DC)在体内预防糖尿病发生的效果。用DC核提取物进行的凝胶迁移试验证实了NF-κB ODN对NF-κB DNA结合的特异性抑制。NF-κB ODN DC的共刺激分子表达、白细胞介素(IL)-12产生以及呈递同种异体和胰岛相关抗原的免疫刺激能力均被显著抑制。NF-κB ODN使DC对脂多糖刺激具有抗性。向6-7周龄的NOD小鼠注射2×10⁶个NF-κB ODN DC可有效预防糖尿病的发生。来自NF-κB ODN DC处理动物胰腺淋巴结的T细胞对胰岛抗原反应低下,干扰素-γ和IL-2产生量低。这些发现为自身免疫性糖尿病的发病机制提供了新见解,并可能导致新预防策略的开发。

相似文献

1
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity.通过给予缺乏核转录因子-κB活性的树突状细胞预防非肥胖糖尿病(NOD)小鼠患糖尿病。
Diabetes. 2003 Aug;52(8):1976-85. doi: 10.2337/diabetes.52.8.1976.
2
Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium.用蝉拟青霉乙醇提取物处理未成熟树突状细胞预防1型糖尿病。
Methods Find Exp Clin Pharmacol. 2008 Jul-Aug;30(6):421-9. doi: 10.1358/mf.2008.30.6.1186083.
3
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.通过全身给予缺乏核因子-κB活性的未成熟受体树突状细胞延长心脏移植存活时间。
Ann Surg. 2005 Mar;241(3):497-505. doi: 10.1097/01.sla.0000154267.42933.5d.
4
Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.非肥胖糖尿病小鼠树突状细胞中升高的核因子κB激活导致抗原呈递细胞功能增强。
J Immunol. 2002 Jan 1;168(1):188-96. doi: 10.4049/jimmunol.168.1.188.
5
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.通过用NF-κB寡脱氧核糖核苷酸诱饵和编码CTLA4-Ig的腺病毒载体进行基因工程改造的树突状细胞显著延长心脏同种异体移植的存活时间。
J Immunol. 2002 Sep 15;169(6):3382-91. doi: 10.4049/jimmunol.169.6.3382.
6
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.应用受体来源的树突状细胞诱导供体特异性T细胞低反应性。
Transplant Proc. 2004 Jun;36(5):1592-4. doi: 10.1016/j.transproceed.2004.04.099.
7
Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.用核因子-κB诱饵寡脱氧核苷酸修饰的树突状细胞延长肝移植存活时间
World J Gastroenterol. 2004 Aug 15;10(16):2361-8. doi: 10.3748/wjg.v10.i16.2361.
8
Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.通过未成熟树突状细胞和亚剂量西罗莫司治疗实现心脏移植长期存活的机制性见解。
J Heart Lung Transplant. 2006 Mar;25(3):310-9. doi: 10.1016/j.healun.2005.10.005. Epub 2006 Jan 25.
9
NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.核因子κB的过度激活对非肥胖糖尿病小鼠巨噬细胞的抗原呈递细胞功能有不同影响。
J Immunol. 2003 Feb 15;170(4):1770-80. doi: 10.4049/jimmunol.170.4.1770.
10
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.使用经核因子-κB诱饵寡脱氧核糖核苷酸处理的树突状细胞延长心脏移植存活时间。
Mol Ther. 2000 May;1(5 Pt 1):430-7. doi: 10.1006/mthe.2000.0060.

引用本文的文献

1
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.耐受性疫苗中的前沿递送系统和佐剂:综述
Pharmaceutics. 2022 Aug 25;14(9):1782. doi: 10.3390/pharmaceutics14091782.
2
Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune Diseases.新兴细胞疗法治疗抗髓过氧化物酶血管炎及其他自身免疫性疾病。
Front Immunol. 2021 Jul 29;12:642127. doi: 10.3389/fimmu.2021.642127. eCollection 2021.
3
Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.
耐受原性树突状细胞可减轻实验性抗髓过氧化物酶性肾小球肾炎。
J Am Soc Nephrol. 2019 Nov;30(11):2140-2157. doi: 10.1681/ASN.2019030236. Epub 2019 Aug 23.
4
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?1 型糖尿病 (T1D) 治疗中的最佳耐受原性树突状细胞:我们可以从非肥胖型糖尿病 (NOD) 小鼠模型中学到什么?
Front Immunol. 2019 May 14;10:967. doi: 10.3389/fimmu.2019.00967. eCollection 2019.
5
Tolerising cellular therapies: what is their promise for autoimmune disease?耐受化细胞疗法:它们在自身免疫性疾病中的前景如何?
Ann Rheum Dis. 2019 Mar;78(3):297-310. doi: 10.1136/annrheumdis-2018-214024. Epub 2018 Nov 2.
6
Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.抗原负载(例如谷氨酸脱羧酶 65)可降低耐受原性树突状细胞(tolDCs)预防非肥胖型糖尿病(NOD)-严重联合免疫缺陷模型中糖尿病以及 NOD 小鼠中糖尿病的能力。
Front Immunol. 2018 Feb 16;9:290. doi: 10.3389/fimmu.2018.00290. eCollection 2018.
7
Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells Toll-Like Receptors 2 and 4.分泌/排泄产物诱导人类树突状细胞产生耐受特性 Toll 样受体 2 和 4。
Front Immunol. 2018 Jan 24;9:11. doi: 10.3389/fimmu.2018.00011. eCollection 2018.
8
Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.聚乙二醇化TLR7配体诱导耐受性树突状细胞用于治疗1型糖尿病
PLoS One. 2015 Jun 15;10(6):e0129867. doi: 10.1371/journal.pone.0129867. eCollection 2015.
9
Targeting dendritic cell function during systemic autoimmunity to restore tolerance.在系统性自身免疫期间靶向树突状细胞功能以恢复免疫耐受。
Int J Mol Sci. 2014 Sep 16;15(9):16381-417. doi: 10.3390/ijms150916381.
10
Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.使用双尺寸微球将免疫抑制因子组合递送至树突状细胞。
J Mater Chem B. 2014 May 7;2(17):2562-2574. doi: 10.1039/C3TB21460E.